Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A clinically relevant modification to existing inhaler therapy.

A J Ward1, N Kassem, J M Evans

  • 1Department of Thoracic Medicine, King's College School of Medicine and Dentistry, London, U.K.

Respiratory Medicine
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving the visibility of Rare Diseases in General Medical Practice.

Irish medical journal·2025
Same author

Genetic services survey-experience of people with rare diseases and their families accessing genetic services in the Irish Republic.

Journal of community genetics·2023
Same author

Designing rare disease care pathways in the Republic of Ireland: a co-operative model.

Orphanet journal of rare diseases·2022
Same author

The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents.

Integrative medicine (Encinitas, Calif.)·2020
Same author

The Functional Medicine Approach to COVID-19: Primer on SARS-CoV-2 Testing.

Integrative medicine (Encinitas, Calif.)·2020
Same author

The impact of gonad shielding in anteroposterior (AP) pelvis projections in an adult: A phantom study utilising digital radiography (DR).

Radiography (London, England : 1995)·2020

A modified inhaled salbutamol formulation showed greater bronchodilation in larger airways for asthma patients. However, the new inhaler device did not outperform the standard Rotahaler.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Respiratory System

Background:

  • Asthma management relies on effective inhaled bronchodilators.
  • New drug formulations and inhaler devices aim to improve therapeutic outcomes.
  • Evaluating novel delivery systems is crucial for optimizing inhalation therapy.

Purpose of the Study:

  • To assess the efficacy of a modified salbutamol formulation delivered via a new inhaler device.
  • To compare the bronchodilating effects of the modified formulation against conventional salbutamol.
  • To evaluate the performance of the new inhaler device against a standard Rotahaler.

Main Methods:

  • A randomized, double-blind, cross-over trial involving 11 patients with moderate-to-severe asthma.
  • Measurement of airway calibre parameters, including FEV1 and Vmax30, before and after inhalation.

Related Experiment Videos

  • Comparison of outcomes between the modified salbutamol formulation in the new inhaler and conventional salbutamol in a Rotahaler.

    • Main Results:

    • The modified salbutamol formulation demonstrated significantly greater bronchodilation in larger airways when used with the Rotahaler.
    • The novel inhaler device did not exhibit superiority over the standard Rotahaler in this study.
    • In vitro expectations regarding the new inhaler's performance were not fully met in vivo.

    Conclusions:

    • The modified salbutamol formulation shows promise for enhancing bronchodilation in larger airways.
    • The tested new inhaler device requires further refinement to match in vitro performance.
    • Findings suggest potential for improved inhalation therapy strategies, warranting further investigation.